Mid-Day Gainers Mar. 7, 2014: SKUL, SMSI, DLIA, BIG, CVM, KFY, GTAT

Loading...
Loading...
Moving up:
  • Skullcandy SKUL - up 33% - Reports Q4 EPS of $0.13 vs $0.09 est; revenue of $72.20M vs $71.88M est. Sees FY2014 EPS $0.10-0.14 vs $0.10 est.
  • Smith Micro Software SMSI - up 29% - Reports Q4 EPS of $(0.01) vs $(0.03) est; revenue of $11.80M vs $11.77M est.
  • dELiA*s DLIA - up 18% - 13G filing from Tiger Global on dELiA*s shows raised stake from 4.92% as of Dec. 31st to 6.3%.
  • Big Lots BIG - up 17% - Reports Q4 EPS from cont ops of $1.39 vs $1.42 est; revenue of $1.64B vs $1.62B est. Sees FY 2014 EPS from cont Oops $2.25-$2.45 vs $2.95 est.
  • CEL-CSI CVM - up 10.3% - Recently declared its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine* (Leukocyte Interleukin, Injection) has activated its first U.S. clinical trial expansion site at 21st Century Oncology in Greenville, North Carolina via Tech Sonian.
  • Korn/Ferry International KFY - up 10.3% - Reports Q3 EPS of $0.31 vs $0.34 est; revenue of $242.20M vs $229.23M est. Sees Q4 EPS $0.35-0.41 vs $0.37 est; sees ree sales $240.0M-250.0M.
  • GT Advanced GTAT - up 4.1% - Upgraded by Credit Suisse from Neutral to Outperform.
  • Cross Country Healthcare CCRN - up 8.5% - Upgraded by Cantor Fitzgerald from Neutral to Buy, raises price target to $10. Upgraded by Citigroup from Neutral to Buy.
  • Foot Locker FL - up 5.8% - Reports Q4 EPS of $0.82 vs $0.76 est; revenue of $1.79B vs $1.76B est, comps up 5.3%.
  • Plug Power PLUG - up 3% - May be in anticipation of CNBC appearance later this morning.
  • Genocea GNCA - up 3.7% - Momentum continuing in the name. Stock is up 26 percent this week alone.
  • The Fresh Market TFM - up 0.5% - Reports Q4 EPS of $0.39 vs $0.44 est; revenue of $425.80M vs $433.31M est.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...